Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of three DPP-4 inhibitors on 24-hour blood glucose, incretin hormones and islet function in type 2 diabetes
2013-005570-22Phase 4Active
- Sponsor
- Lund University
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sitagliptin, vildagliptin and saxagliptin in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Lund University. Primary endpoint: Postprandial plasma glucose AUC over 180 minutes after each meal. Started Jan 2014; status: active.
02
Drugs
sitagliptinvildagliptinsaxagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2013-005570-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005570-22.